{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:06:18Z","timestamp":1783933578917,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2024.e24161","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T14:30:53Z","timestamp":1704465053000},"page":"e24161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["LiveBoost: A GB-based prediction system for liver fibrosis in chronic hepatitis B patients in China - A multi-center retrospective study"],"prefix":"10.1016","volume":"10","author":[{"given":"Guoxiang","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fankun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-8994","authenticated-orcid":false,"given":"Wei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2024.e24161_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24161_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00046-19","article-title":"Hepatitis B virus: Advances in prevention, diagnosis, and therapy","volume":"33","author":"Nguyen","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e24161_bib3","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e24161_bib4","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s40265-019-01126-9","article-title":"Fibrosis in chronic liver disease: an update on diagnostic and treatment modalities","volume":"79","author":"Manka","year":"2019","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e24161_bib5","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e24161_bib6","series-title":"Liver Biopsy. StatPearls. Treasure Island (FL)","author":"Pandey","year":"2022"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24161_bib7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24161_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24161_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e24161_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105183","article-title":"The frequency and determinants of liver stiffness measurement failure: a retrospective study of \"real-life\" 38,464 examinations","volume":"9","author":"Ji","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24161_bib11","doi-asserted-by":"crossref","first-page":"916","DOI":"10.14309\/ajg.0000000000000153","article-title":"Impact of obesity and alanine aminotransferase levels on the diagnostic accuracy for advanced liver fibrosis of noninvasive tools in patients with nonalcoholic fatty liver disease","volume":"114","author":"Petta","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24161_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24161_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"Non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24161_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","article-title":"Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update","volume":"11","author":"Shiha","year":"2017","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24161_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/1751-2980.12854","article-title":"Consensus on the diagnosis and treatment of hepatic fibrosis (2019)","volume":"21","year":"2020","journal-title":"J Dig Dis"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e24161_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24161_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24161_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","article-title":"Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients","volume":"64","author":"Kim","year":"2016","journal-title":"J. Hepatol."},{"issue":"40","key":"10.1016\/j.heliyon.2024.e24161_bib19","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.3748\/wjg.v27.i40.6794","article-title":"Artificial intelligence in gastroenterology: a state-of-the-art review","volume":"27","author":"Kr\u00f6ner","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e24161_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2018.07.041","article-title":"Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning","volume":"35","author":"Wei","year":"2018","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24161_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24161_bib22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e24161_bib23","series-title":"WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection","year":"2015"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24161_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24161_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.dld.2007.10.011","article-title":"Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B","volume":"40","author":"Shin","year":"2008","journal-title":"Dig. Liver Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24161_bib26","article-title":"The diagnostic accuracy and clinical utility of three noninvasive models for predicting liver fibrosis in patients with HBV infection","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e24161_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23960","article-title":"Performance of noninvasive tools for identification of minimal liver fibrosis in patients with hepatitis B virus infection","volume":"35","author":"Zhang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24161_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.14218\/JCTH.2022.00098","article-title":"Advantages of a novel model for predicting hepatic fibrosis in chronic hepatitis B virus carriers compared with APRI and FIB-4 scores","volume":"10","author":"Kang","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24161_bib29","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1186\/s12879-019-4459-4","article-title":"The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e24161_bib30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jvh.12279","article-title":"APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS)","volume":"21","author":"Teshale","year":"2014","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24161_bib31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis","volume":"61","author":"Xiao","year":"2015","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e24161_bib32","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nmeth.4526","article-title":"Points of significance: machine learning: a primer","volume":"14","author":"Bzdok","year":"2017","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24161_bib33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized nutrition by prediction of glycemic responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e24161_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40364-020-00215-2","article-title":"FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients","volume":"8","author":"Lu","year":"2020","journal-title":"Biomark. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24161_bib35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1155\/2013\/127962","article-title":"An MLP classifier for prediction of HBV-induced liver cirrhosis using routinely available clinical parameters","volume":"35","author":"Cao","year":"2013","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24161_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55445-8","article-title":"Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts","volume":"9","author":"Mueller-Breckenridge","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e24161_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1471-2334-10-251","article-title":"Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Infect. Dis."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024001920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024001920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:19:50Z","timestamp":1783930790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024001920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844024001920"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24161","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LiveBoost: A GB-based prediction system for liver fibrosis in chronic hepatitis B patients in China - A multi-center retrospective study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e24161"}}